JP2007515402A5 - - Google Patents

Download PDF

Info

Publication number
JP2007515402A5
JP2007515402A5 JP2006541282A JP2006541282A JP2007515402A5 JP 2007515402 A5 JP2007515402 A5 JP 2007515402A5 JP 2006541282 A JP2006541282 A JP 2006541282A JP 2006541282 A JP2006541282 A JP 2006541282A JP 2007515402 A5 JP2007515402 A5 JP 2007515402A5
Authority
JP
Japan
Prior art keywords
isomer
salbutamol
mammal
dystomer
automer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006541282A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007515402A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/037966 external-priority patent/WO2005051092A2/en
Publication of JP2007515402A publication Critical patent/JP2007515402A/ja
Publication of JP2007515402A5 publication Critical patent/JP2007515402A5/ja
Pending legal-status Critical Current

Links

JP2006541282A 2003-11-20 2004-11-12 哺乳動物および鳥類の体脂肪および体重の減少方法 Pending JP2007515402A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52437603P 2003-11-20 2003-11-20
PCT/US2004/037966 WO2005051092A2 (en) 2003-11-20 2004-11-12 Method of decreasing fat deposits and body weight in mammals and birds
US10/987,665 US20050113456A1 (en) 2003-11-20 2004-11-12 Method of decreasing fat deposits and body weight in mammals and birds

Publications (2)

Publication Number Publication Date
JP2007515402A JP2007515402A (ja) 2007-06-14
JP2007515402A5 true JP2007515402A5 (https=) 2007-07-26

Family

ID=34595131

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006541282A Pending JP2007515402A (ja) 2003-11-20 2004-11-12 哺乳動物および鳥類の体脂肪および体重の減少方法

Country Status (8)

Country Link
US (2) US20050113456A1 (https=)
EP (1) EP1684593A4 (https=)
JP (1) JP2007515402A (https=)
AU (1) AU2004292416B2 (https=)
CA (1) CA2545559A1 (https=)
NZ (1) NZ547178A (https=)
WO (1) WO2005051092A2 (https=)
ZA (1) ZA200604077B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2615173C (en) 2005-07-14 2012-01-03 Lipothera, Inc. Sustained release enhanced lipolytic formulation for regional adipose tissue treatment
US20070264313A1 (en) * 2006-05-12 2007-11-15 Musser Robert E Methods and compositions relating to animal dietary acids
JP2010506941A (ja) * 2006-10-17 2010-03-04 リセラ,インク. 甲状腺眼症の治療のための方法、組成物及び製剤
WO2009073051A1 (en) * 2007-12-03 2009-06-11 Bridge Pharma, Inc. Use of rr/sr-ractopamine
WO2010027259A1 (en) 2008-09-02 2010-03-11 N.V. Nutricia Nutritional compositions with coated lipid globules
WO2010068086A1 (en) 2008-12-11 2010-06-17 N.V. Nutricia Nutritional compositions with large lipid globule size
US9132084B2 (en) * 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
GB2487868B (en) * 2010-01-15 2014-12-10 Neothetics Inc Lyophilized cake formulations
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
UA111822C2 (uk) * 2010-11-24 2016-06-24 Общєство С Огранічєнной Отвєтствєнностью "Новамедіка" Монотерапевтичий препарат селективного ліпофільного бета-агоніста тривалої дії і спосіб косметичного лікування ожиріння і контурного випинання
ES2693519T3 (es) 2013-11-01 2018-12-12 N.V. Nutricia Composición lipídica para mejorar la composición corporal durante el crecimiento de recuperación
KR102273533B1 (ko) * 2015-06-15 2021-07-06 삼성전자 주식회사 무선 통신 시스템에서 서비스 제공 방법 및 장치
WO2017064304A1 (en) 2015-10-15 2017-04-20 N.V. Nutricia Infant formula with special lipid architecture for promoting healthy growth
ES2987545T3 (es) 2016-12-09 2024-11-15 Nutricia Nv Composición nutricional para su uso en la mejora del rendimiento cognitivo y/o la prevención del deterioro cognitivo

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0085514A3 (en) * 1982-01-28 1984-02-29 Beecham Group Plc Compositions comprising a beta-antagonist and a beta-agonist, their preparation, and their use in treating obese humans and animals
GB8604134D0 (en) * 1986-02-19 1986-03-26 Glaxo Group Ltd Veterinary preparations
IE60964B1 (en) * 1986-12-11 1994-09-07 Roussel Uclaf Zootechnical compositions containing a beta-adrenergic
US5147869A (en) * 1986-12-11 1992-09-15 Roussel Uclaf Zootechnical compositions
US5541188A (en) * 1987-09-15 1996-07-30 The Rowett Research Institute Therapeutic applications of beta-adrenergic agonists
US5530029A (en) * 1987-09-15 1996-06-25 The Rowett Research Institute Therapeutic applications of clenbuterol
FR2642075B1 (fr) * 1989-01-25 1991-04-26 Pasteur Institut Polypeptides ayant une activite de recepteur (beta)-adrenergique chez l'homme, impliques dans la reponse lipolytique, acides nucleiques codant pour ces polypeptides et utilisation de ces polypeptides pour le criblage de substance active sur ces polypeptides
DK339289D0 (da) * 1989-07-07 1989-07-07 Dak Lab As Farmaceutisk praeparat
JP3085705B2 (ja) * 1990-01-05 2000-09-11 セプラカー・インコーポレーテツド 喘息の治療のための光学的純粋r(−)アルブテロール
US5362755A (en) * 1990-01-05 1994-11-08 Sepracor, Inc. Method for treating asthma using optically pure (R)-albuterol
JP3358631B2 (ja) * 1993-05-17 2002-12-24 三菱瓦斯化学株式会社 メタノ−ルの脱水素方法
US5399765A (en) * 1994-05-23 1995-03-21 Sepracor, Inc. Enantioselective preparation of optically pure albuterol
US5545745A (en) * 1994-05-23 1996-08-13 Sepracor, Inc. Enantioselective preparation of optically pure albuterol
US5698199A (en) * 1995-03-10 1997-12-16 Kao Corporation Lipolysis acceleration method
US5708036A (en) * 1996-01-29 1998-01-13 Pesterfield, Jr.; E. Charles Method of treating premature uterine contractions using the optically active R(-)-isomer of albuterol
CA2286913C (en) * 1997-04-30 2008-12-09 Bridge Pharma, Inc. Composition and methods using an eutomer
US7767708B2 (en) * 1998-11-04 2010-08-03 Schering-Plough Animal Health Corp. Growth stimulant compositions
US6683115B2 (en) * 1999-06-02 2004-01-27 Theravance, Inc. β2-adrenergic receptor agonists
GB0030171D0 (en) * 2000-12-11 2001-01-24 Cipla Ltd Process for preparing isomers of salbutamol

Similar Documents

Publication Publication Date Title
RU2000131222A (ru) Новые аналоги жирных кислот для лечения ожирения, гипертензии и жировой инфильтрации печени
US20080020019A1 (en) Method of decreasing fat deposits and body weight in mammals and birds
JP2007515402A5 (https=)
JPH04230624A (ja) 犬の加齢による認知機能障害を治療する方法
JP2001031566A (ja) ペットの問題行動抑制組成物
CA2286913C (en) Composition and methods using an eutomer
WO2012033874A1 (en) Method of treating compulsive self-injurious behaviors
RU2005140739A (ru) Применение альфа-кетоглутаровой кислоты для лечения недостаточности питания или состояния с высоким уровнем глюкозы в плазме
US9358238B2 (en) Method of enhancing the performance of broiler chickens
JP4629964B2 (ja) ウシの消化器疾患治療剤
US20080070990A1 (en) Use of ractopamine enantiomers
AU691975B2 (en) Use of selegiline to prolong life span
RU2005120958A (ru) Способ профилактики и лечения желудочно-кишечных заболеваний у животных и птиц
JP2004091475A (ja) 高遊離脂肪酸血症の予防または改善用組成物
JPH11222429A (ja) 動物の外部寄生虫の防除方法
RU2024119390A (ru) Применение аминопиразольных соединений
HK1060697B (en) Novel uses of combined 5-ht1a agonists and serotonin reuptake inhibitors
Kyriakis et al. Anorexia-like wasting syndromes in pigs
HK1060697A1 (en) Novel uses of combined 5-ht1a agonists and serotonin reuptake inhibitors
CN1882320A (zh) 减少哺乳动物和鸟类的脂肪堆积物和体重的方法
JP2004513915A (ja) 複合的な選択的ドーパミンd2レセプターアンタゴニストおよび5−ht1aレセプターアゴニストの新規な使用
HK1060698A (en) Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists
Kyriakis ANOREXIA-LIKE WASTING SYNDROMES IN
MXPA99009783A (en) Composition and methods using an eutomer